[1]杨晓明, 高福, 俞永新, 等. 当代新疫苗[M]. 北京: 高等教育出版社, 2020
[2]Wang Y, Zhang Y, Wu H, et al. Safety and immunogenicity of a quadrivalent
inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind,
active-controlled phase 1 clinical trial [J]. Vaccine, 2021, 39(29): 3871-8.
DOI:10.1016/j.vaccine.2021.05.070.
[3]Barría Maria Ines, Luis G J , Cheryl S ,et al.Localized mucosal response to intranasal live attenuated influenza vaccine in adults.[J].Journal of Infectious Diseases, 2013(1):115-124.DOI:10.1093/infdis/jis641.
[4]https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-northern-hemisphere-influenza-season
[5]https://www.cdc.gov/flu/prevent/trivalent.htm
[6]https://cdn.who.int/media/docs/default-source/influenza/who-influenza-recommendations/vcm-northern-hemisphere-recommendation-2023-2024/202302_qanda_recommendation.pdf?sfvrsn=4f30952b_1
[7]中国疾病预防控制中心. 中国流感疫苗预防接种技术指南(2023-2024)
[8]https://mp.weixin.qq.com/s/y-B8e5GLJ2hn3cgsD_y5dg
[9]https://www.cdc.gov/flu/prevent/vaccinations.htm#when
[10]Turner P J, Southern J, Andrews N J, et al. Safety of live attenuated influenza
vaccine in young people with egg allergy: multicentre prospective cohort study [J].
BMJ, 2015, 351: h6291. DOI:10.1136/bmj.h6291.
[11]https://www.who.int/zh/news/item/23-02-2024-recommendations-announced-for-influenza-vaccine-composition-for-the-2024-2025-northern-hemisphere-influenza-season